FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488 | +48700.0% | 65 | -11.0% | 0.00% | – |
| Q2 2023 | $1 | -99.5% | 73 | -99.7% | 0.00% | – |
| Q1 2023 | $204 | – | 25,400 | +41539.3% | 0.00% | – |
| Q2 2022 | $0 | – | 61 | -14.1% | 0.00% | – |
| Q1 2022 | $0 | – | 71 | +31.5% | 0.00% | – |
| Q4 2021 | $0 | – | 54 | +134.8% | 0.00% | – |
| Q3 2021 | $0 | – | 23 | -58.2% | 0.00% | – |
| Q2 2021 | $0 | – | 55 | +266.7% | 0.00% | – |
| Q1 2021 | $0 | – | 15 | -80.8% | 0.00% | – |
| Q3 2020 | $0 | – | 78 | +239.1% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 23 | -93.3% | 0.00% | – |
| Q4 2019 | $2,000 | – | 342 | +159.1% | 0.00% | – |
| Q3 2019 | $0 | – | 132 | -10.8% | 0.00% | – |
| Q2 2019 | $0 | – | 148 | +410.3% | 0.00% | – |
| Q1 2019 | $0 | – | 29 | +141.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 12 | -84.4% | 0.00% | – |
| Q3 2018 | $1,000 | – | 77 | +234.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 23 | -59.6% | 0.00% | – |
| Q4 2017 | $1,000 | – | 57 | +850.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |